At the beginning of 2023, Spirecut moved from Fribourg to Muttenz. The last three years have seen a steep development curve and several awards. The ‘100 fürs Baselbiet’ initiative, which means ‘100 for the Basel region’, is a cornerstone of this success story.
Spirecut will partner with Sovereign Medical and Prof. Joanne Lord from the University of Southampton
Spirecut & Sovereign Medical kicked off surgeons & radiologists trainings in London and Manchester on October 12th and 13th.
A new minimally invasive procedure developed by Prof. Frédéric Schuind and his start-up Spirecut offers a quicker and less invasive solution. Using the Sono-Instruments®, specialists can operate under local anesthesia without making a surgical incision.
Spirecut, a Muttenz-based medtech start-up, is revolutionizing hand surgery with a groundbreaking ultrasound-guided technique spearheaded by CEO Frédéric Schuind. Moving away from traditional incision-based methods, Spirecut’s innovation requires a minor puncture to treat common hand disorders such as trigger finger and carpal tunnel syndrome.”
On Friday, June 23rd, Spirecut hosted a training session at Sitem-insel AG, located in Bern, Switzerland. The session primarily focused on the ultrasound-guided percutaneous surgical treatments of two prevalent hand conditions: trigger fingers and carpal tunnel syndrome. Participants included future Key Opinion Leaders (KOLs).
Spirecut has recently joined the Global Nerve Foundation (GNF) as its first-ever Start-up Partner. GNF is an organization dedicated to the betterment of individuals with nerve-related conditions globally.
This partnership resonates with Spirecut’s mission to enhance patient outcomes through ultrasound guidance. The congruity of our visions makes this collaboration a step forward in the direction of patient care enhancement.
Prof Frédéric Schuind, Spirecut’s founder and CEO, recently participated in the X-Health.show podcast. The discussion centered around the latest breakthroughs in hand surgery, with a particular emphasis on trigger finger and carpal tunnel syndrome treatments.
Spirecut’s European patent has been officially approved. This represents a significant milestone for our company as it reinforces our intellectual property portfolio. This development will enable us to expand our solutions across Europe, fostering innovation and enhancing healthcare in the region.
The study involved 30 adult participants, equally divided between the two conditions under investigation. One of the critical aspects of this research was the assessment of safety, gauged by the number of severe peri- and post-operative adverse events.
Representatives from Spirecut (Clémence Hermann, and Edmond Sula) recently attended Startup Days (SUD), Switzerland’s premier startup conference, providing insights into our innovative solutions and opportunities for meaningful discussions and partnerships.
Spirecut has opted to establish its new headquarters in the canton of Basel-Landschaft. We now operate out of “The 5th Floor” co-working space in Muttenz with the help of the “100 fürs Baselbiet” program run by BLKB and with the support of Basel Area Business & Innovation.
The signature yearly event brings together Swissnex staff worldwide and relevant Swiss stakeholders to exchange the latest trends internationally and explore potential collaborations with Switzerland. This year’s event topic is “Pushing the boundaries in health innovation.”
IRCAD offers an exceptional training facility, which welcomes over 8,800 surgeons from all surgical specialities annually. The unique involvement and self-commitment of more than 800 international experts are the key to the Institute’s success.